SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-19-000034
Filing Date
2019-05-08
Accepted
2019-05-08 17:30:38
Documents
59
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2019q1bhvn10-q.htm   iXBRL 10-Q 856676
2 EXHIBIT 10.1 a2019q1bhvn10-qex101.htm EX-10.1 132831
3 EXHIBIT 31.1 a2019q1bhvn10-qex311.htm EX-31.1 13556
4 EXHIBIT 31.2 a2019q1bhvn10-qex312.htm EX-31.2 13527
5 EXHIBIT 32.1 a2019q1bhvn10-qex321.htm EX-32.1 8808
  Complete submission text file 0001689813-19-000034.txt   4010860

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20190331.xsd EX-101.SCH 37498
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20190331_cal.xml EX-101.CAL 46232
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20190331_def.xml EX-101.DEF 127940
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20190331_lab.xml EX-101.LAB 418754
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20190331_pre.xml EX-101.PRE 226050
11 EXTRACTED XBRL INSTANCE DOCUMENT a2019q1bhvn10-q_htm.xml XML 498540
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 19807973
SIC: 2834 Pharmaceutical Preparations